People
Synaptiq Therapeutics launches and acquires clinical-stage SYN-001 programme
24 July 2026 - A consortium of European and US-based investors and clinical-stage company Nobias Therapeutics, which is majority-backed by Medical Excellence Capital, announced on Thursday the launch ...
WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year
22 July 2026 - WuXi AppTec, a China-based global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organisation), announced on Tuesday that it has been named in the FTSE4Good Ind...
Kibow Biotech receives AANP Corporation of the Year Award
20 July 2026 - Kibow Biotech, a developer of probiotic supplements for maintaining kidney health, announced on Friday that it has been named the recipient of The American Association of Naturopathic P...
EDX Medical to provide molecular profiling services to Astron Health
8 July 2026 - EDX Medical Group plc (LSE: EDX) announced on Wednesday that it has been appointed by Astron Health Ltd to provide molecular profiling products and services in the UK, expanding its prec...
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
29 June 2026 - Consumer healthcare group Futura Medical plc (AIM: FUM) disclosed on Monday that it has terminated its US commercial agreement with Haleon plc (LSE: HLN) (NYSE: HLN) and appointed Marke...
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
26 June 2026 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) said on Friday that it will request a re-examination of the European Medicines Agency's Committee for Medicin...